Menu Search
Equities

Medartis Holding AG

MED:SWX

Medartis Holding AG

Actions
  • Price (CHF)50.80
  • Today's Change1.30 / 2.63%
  • Shares traded4.69k
  • 1 Year change-20.75%
  • Beta1.5063
Data delayed at least 15 minutes, as of Nov 22 2024 16:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CHFIncome statement in CHFView more

Year on year Medartis Holding AG grew revenues 15.96% from 182.82m to 212.01m while net income improved from a loss of 5.78m to a gain of 620.00k.
Gross margin80.53%
Net profit margin1.83%
Operating margin4.43%
Return on assets0.98%
Return on equity1.50%
Return on investment1.13%
More ▼

Cash flow in CHFView more

In 2023, Medartis Holding AG increased its cash reserves by 22.31%, or 4.60m. Cash Flow from Financing totalled 23.20m or 10.94% of revenues. In addition the company generated 19.98m in cash from operations while cash used for investing totalled 37.83m.
Cash flow per share1.98
Price/Cash flow per share26.30
Book value per share20.07
Tangible book value per share15.64
More ▼

Balance sheet in CHFView more

Medartis Holding AG has a Debt to Total Capital ratio of 32.27%, a higher figure than the previous year's 13.46%.
Current ratio4.52
Quick ratio3.15
Total debt/total equity0.4764
Total debt/total capital0.3227
More ▼

Growth rates in CHF

Year on year, growth in earnings per share excluding extraordinary items increased 110.36%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
EPS growth(5 years)-33.71
EPS (TTM) vs
TTM 1 year ago		155.25
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.